Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

presumably the article from today's ST

Director/PDMR Shareholding
RNS
RNS Number : 1591J
Fevertree Drinks PLC
28 March 2018

28 March 2018
Fevertree Drinks plc
("Fever-Tree" or the "Company")

Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 27 March 2018, Jeff Popkin, Non-Executive Director of the Company, purchased 600 ordinary shares in the Company at a price of US $40.50 via US OTC Markets.

Are we mad? £27 or thereabouts for AIM-stock....
Just trying to establish this isn't easy IMHO- the AIM angle being somewhat hidden by most of the wealthier Companies on AIM....
It's about time they spent some money and joined the big game table.
Zero yield
PE is quoted about 70
- DYOR....

what about ASC?
surely that is still an AIM stock

Directorate Change
RNS
RNS Number : 0098K
Fevertree Drinks PLC
05 April 2018

5th April 2018
Fevertree Drinks plc

("Fever-Tree" or the "Company")

Directorate Change
Fever-Tree, the world's leading supplier of premium carbonated mixers, today announces that, following the administration of Conviviality Plc, a company of which David Adams is Chairman, David has tendered his resignation as a Non-Executive Director of the Company with immediate effect and this has been accepted by the Board.
Bill Ronald, Non-Executive Chairman of Fever-Tree commented:
"On behalf of the Board, I would like to thank David for his considerable contribution to the Company since it floated on AIM. David has been a valued member of the Board and I wish him all the best for the future."

proactive investor -

Asos and Fevertree help to push average market cap of AIM companies past £100mln
Share
12:55 09 Apr 2018
Notable success stories such as Fevertree, Asos and Boohoo have helped to push the average market cap of AIM-listed companies up to £111mln – a 49% increase compared to four years ago

Asos’ almost £6bn market cap wouldn’t look out of place on the FTSE 100
The average market capitalisation of companies listed on the Alternative Investment Market (AIM) in London has soared past £100mln for the first time, research from a new study has shown.
According to data gathered by accountancy group Moore Stephens, the average company listed on the junior market was valued at £111mln as of December 2017 – an increase of almost 50% compared to four years earlier (£70mln).
Asos leads the way​
There have been a few notable risers over that timeframe, including online fashion retailers ASOS PLC (LON:ASC) and Boohoo.com PLC (LON:BOO), as well as posh tonic maker Fevertree Drinks PLC (LON:FEVR).
Asos has seen its value swell to almost £6bn, while its rival Boohoo.com’s has seen its stock price more than double since it joined AIM towards the start of 2014, giving it a market cap of £1.7bn.
As for Fevertree, the Chelsea-based mixer maker only floated in November 2014, but it has enjoyed a meteoric rise over the past few years.
It sold shares at 134p ahead of its initial public offering (IPO) back then and those same shares go for around £27 apiece now – a stonking rise of more than 1,500%.
Fevertree’s present market value is a shade over £3bn, which has resulted in a few nice paydays for its two founders and early backers.
Has AIM lost its way?
“The increasing trend in size of AIM companies signifies a positive sentiment to the market,” said Moore Stephens head of capital markets, Marty Lau.
“This also means new issuers tend to be larger, more established companies. This is to the benefit of those companies listed on the market, but brings to light a key question – is this what AIM is all about?”
Lau added: “The external view of the market improves on a snapshot basis with each market capitalisation but there is an impression that as these get larger, smaller companies shouldn’t be on AIM.
“If this trend is being pushed by regulators, there could be a risk that the lines between AIM and the Main Market become blurred, to AIM’s detriment.”
Still space for the small caps …
Despite the rise in average market capitalisations, Moore Stephens study did show that small caps are still the lifeblood of the junior market.
Of the 950 companies currently listed on AIM, 437 (46%) have a market capitalisation of below £25mln and 249 (26%) have a market capitalisation below £10mln.
Still, it’s not always suitable or beneficial for companies with a small market value to go public, as Distil PLC’s (LON:DIS) finance director, Shaun Claydon, explains.
“Due to increasing regulation and ongoing costs of membership, companies which are active users of the market and raise follow on capital will benefit most from their AIM listing.
“By contrast, for the many micro-cap companies on AIM which are under researched, have poor liquidity and rarely tap the market for more funds, the costs of AIM are likely to outweigh the benefits beyond the initial access to public equity capital at IPO.”
AIM bosses optimistic
Moore Stephens’ study also revealed that the bosses of AIM-quoted firms are generally optimistic about their companies and the market as a whole.
More than half of those polled (53%) indicated that they were positive about what the next year holds, while 86% think their company is well-positioned to grow revenues in 2018.
“This confidence is encouraging,” said Lau.
“Despite a period of political and therefore economic uncertainty for both companies and advisors, to be demonstrating such optimism shows that AIM is still an excellent market to do business on.”

Director/PDMR Shareholding
RNS
RNS Number : 3291K
Fevertree Drinks PLC
09 April 2018

09 April 2018
Fevertree Drinks plc
("Fever-Tree" or the "Company")

Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 9 April 2018, Kevin Havelock, a Non-Executive Director of the Company, bought, in aggregate, 10,000 ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") at a volume weighted average price of 2,683.26 pence per Ordinary Share.

AGM Statement
RNS
RNS Number : 3508O
Fevertree Drinks PLC
17 May 2018

17th May 2018
Fevertree Drinks plc
("Fever-Tree", the "Group" or the "Company")

AGM Statement
Bill Ronald, Chairman of Fever-Tree, the world's leading supplier of premium carbonated mixers, will make the following statement at the Group's Annual General Meeting to be held at 11.30am today.
"2017 was another year of strong growth for Fever-Tree with all regions delivering impressive rate of sale growth and market share gains across both the on and off trade.
The first four months of 2018 has seen further positive progress, most notably in the UK where, as market leader, our brand strength, pioneering approach to flavours and formats, as well as our relationships with key customers and spirits partners means we are increasingly well positioned as the wider mixer category continues to evolve.
The transition to our wholly owned operations in the US is continuing to plan. We have made excellent progress, with the Fever-Tree US team now in place ahead of taking direct management of our distribution network and marketing effort on 1st June 2018.
As announced separately this morning, I am delighted to welcome Domenic De Lorenzo to the Board as a Non-Executive Director. As a former FTSE 100 CFO with significant beverages experience I have no doubt he will further strengthen our Board's capabilities.
The Group's performance in the year to date has been encouraging and at this early stage in the year we are trading in line with market expectations for the full year ending 31 December 2018.
We look forward to reporting further on our progress at our interim results in July."

sp got clattered, but have been unable to buy more at the level i wanted .... never mind

Director/PDMR Shareholding
RNS
RNS Number : 8629O
Fevertree Drinks PLC
22 May 2018

22 May 2018
Fevertree Drinks plc
("Fever-Tree" or the "Company")

Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 18 May 2018, Jeff Popkin, Non-Executive Director of the Company, purchased 1,000 ordinary shares in the Company at a price of US $38.50 per ordinary share via US OTC Markets.

£40 not so far away.

09:30 22/06/2018
Broker Forecast - Jefferies International issues a broker note on Fevertree Drinks Plc
Jefferies International today reaffirms its buy investment rating on Fevertree Drinks Plc (LON:FEVR) and raised its price target to 4000p (from 3000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

4000? Never 😀

I thought you had snuffed it Stan. How are you. Yep £40. :-))

Interim Results

Fever-Tree, the world's leading supplier of premium carbonated mixers today announces its Interim Results for the period ended 30 June 2018.

Financial Highlights:

· Revenue up 45% to £104.2m (H1 2017: £71.9m)

· Gross margin of 53.2% (H1 2017: 54.5%)

· Adjusted EBITDA1 up 35% to £34.0m (H1 2017: £25.2m)

· Net cash at period end of £56.4m (H1 2017: £40.5m)

· Diluted EPS up 36% to 22.72 pence (H1 2017: 16.72 pence)

· Interim dividend up 40% to 4.22 pence per share (H1 2017: 3.01 pence)


Operational Highlights:

· Transition to wholly-owned operations in the US on 1 June 2018 with the Fever-Tree US team now directly managing marketing, sales and distribution efforts

· Further strong growth in UK, extending our position as the No 1 mixer brand in the UK Off-Trade*

· Successful roll out of the Refreshingly Light low-calorie range in the UK

· New distribution agreement with Grupo Damm for the Spanish market

· Further strengthening of the Board with three non-executive Directors appointed during the period with a breadth of relevant beverage and international experience

· Successful sponsorship of the inaugural Fever-Tree Championships at Queen's Club, London

* (IRI - Total UK Retail Mixer Market value share - 13 weeks to 17/6/18).

Post Period End:

· Agreement signed with Southern Glazer's Wine and Spirits ("SGWS"), the largest North American wine and spirits distribution company, to be the Group's exclusive distribution partner in the On-Trade channel across 29 US states effective from 1 August 2018


Tim Warrillow, CEO of Fever-Tree said:

"The first half of 2018 has been one of major progress for Fever-Tree. The Group delivered a strong performance, most notably in the UK, as we continue to drive and lead the evolution of the wider mixer category. Furthermore, our relationships with key customers and spirits partners mean we are increasingly well positioned as the growing move to premiumisation and long mixed drinks continues to develop across the globe.

We have successfully launched our wholly owned US operations with a talented team recruited and now in place. The exclusive distribution agreement with SGWS, the largest North American wine and spirits distribution company, is a significant endorsement and provides a strong platform for Fever-Tree US in 2019 and beyond.

Given the strong performance in the first half of the year, the Board anticipates that the outcome for the full year will be comfortably ahead of its expectations."

1 Adjusted EBITDA is earnings before interest, tax, depreciation, amortisation, share based payment charges and finance costs

hohohoho!!!

as i posted yesterday on advfn at 13:56 ......
the continuing searing weather will have some sentimental effect on shares in companies like FEVR
in any case, having tucked away the profit from OCDO, i noted FEVR had dipped a little and was just touching 25 dma, so i have had a further small dabble at 3449


what a very lucky call that was

Well done Cynic, pour yourself a Blackwoods Vintage Dry gin with a Fevertree tonic!😃

I've sold my (belated) small holding @3905 - too small to turn down £7 a share profit - I'll look again at any weakness - good luck to those with decent size holdings.

Gap to close.